Human Nature is Unique in the Mismatch between The usual diet and the need for “Food for the Brain” (Marine Fat,DHA). Adding Marine Fat is Beneficial in Schizophrenia and Manic-Depressive Psychosis. This Underlines Brain Dysfunction in these Neurological Disorders is Associated with Deficient Intake of Marine Fat(DHA)

Broadhurst C.L. Cunane S.C. Crawford M.A. (1998). Rift valley lake fish and shellfish provided brain specific nutrition for early homo. Brit J Nutrit. 79, 3–21.

Crawford M.A. (1992). The role of dietary fatty acids in biology: their place in the evolution of the human brain. Nutrition Reviews, 50, 3–11.

Dewey K.G. Peerson J.M. Brown K.H. (1995). Growth of breast-fed infants deviates form current reference data: a pooled analyses of US, Canadian and European data sets. Pediatrics, 96, 495–502.

Eisenberg J.F. Wilson D.E. (1978). Relative brain size and feeding strategies in the Chiroptera. Evolution, 32, 740–51.

Gibson R.A. Byard R.W. Makrides M. . (1994). Brain polyunsaturated fatty acids and SIDS. In Rognum TO ed. 3rd International SIDS conf. Stavanger: abstr. 142.

Hardy A. (1960). Was man more aquatic in the past? New Scientist, 642–45.

Harvey P.H. Krebs Jr . (1990). Comparing brains. Science, 249, 140–6.

Horrobin D.F. (1989). The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res, 30, 193–208.

La Mantia A.S. (1999). Forebrain induction, retinoic acid, and vulnerability to schizophrenia. Biol Psychiatry, 46, 19–30.

Leaf A. Kang J.X. Ziao Y-F Billman G.E. Voskoyl R.A. (1999). Functional and electrophysologic effects of polyunsaturated fatty acids on excitable tissues: heart and brain. ProstagIand, Leucotr Essen Fatty Acids, 50, 307–312.

Mahadik S.P. Mukherjee S. Horrobin D.J. (1996). Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects. Psychiatry Res. 63, 133–142.

Mellor J.E. Lalughame J.D.E. Peet M. (1995). Schizophrenic symptoms and dietary intake for n-3 fatty acids. Schiz Res, 18, 855–886.

Morgan E. (1985). The Descent of Woman. Souvenir Press, London. Postscript refers IP La Luniere suggesting extensive flooding in Northern Africa during the fossil gap of 4–8 mill. years ago.

Nyland H. (2000). Treatment of multiple sclerosis with omega-3 (Dagens medisin, sept. 22).

Peet M. Horrobin D.F. (2000). A multicentre trial of ethyl eicosapentaenoic acid in schizophrenia. Schiz Res, 41, 225S.

Rush D. (1982). Effects of changes in protein and calorie intake during pregnancy on the growth of the human fetus. In: Enkin M. Chalmers I. (Eds.), Effectiveness and Satisfaction in Antenatal Care. Clinics in developmental Medicine Nos 81/82, Chapter 6. Spastics International Medical Publications, pp. 92–113.

Saugstad L.F. (1981). Weight ofall births and infant mortality. J Epidemiol. Commun Health, 35, 185–191.

Saugstad L.F. (1994a). The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia. Int J Psychophysiol. 18, 189–203.

Saugstad L.F. (1997). Optimal foetal growth in the reduction of learning and behaviour disorder and prevention of Sudden Infant Death (SIDS) after the first month. Int J Psychophysiol. 27, 107–121.

Saugstad L.F. (1999b). Optimality of the birth population reduces learning and behaviour disorders and sudden infant death after the first month. Acta Pediat. Supple 429, 9–28.

Saugstad L.F. (2000). Suicide and resilience. The role of mental illness, psychotropic medication and abuse. Int Med J., 7, 169–8.

Saugstad L.F. (2001). Manic depressive psychosis and schizophrenia are part of human diversity in growth and maturation and nutritional neurological disorders associated with a deficient intake of marine fat. In press.

Saugstad O.D. (1988). Hypoxanthine as an indicator of hypoxia. Its role in health and disease through free radical production. Pediatr Res. 23;443–450

Saugstad O.D. Rognum T.O. (1995). Does hypoxia preceede death in SIDS victims? In: Rognum T.O. (Ed.) Sudden Infant Death Syndrome. New Trends in the Nineties. Scandinavian University Press, pp. 159–163.

Severus Ahrens W.E. , (2000). Omega -3 fatty acids in psychiatry. Nervenarzt. 71, 58–62.

Spector A.A. (1999). Essentiality of Omega-3 fatty acids. Workshop on the essentiality of and dietary reference intakes (DRIS) for Omega-6 and Omega-3 fatty acids. National Institutes of Health, Bethesda Maryland, USA.

Stoll A.L. Locke C.A. Marangell L.B. Severus W.E. (1999). Omega-3 fatty acids and bipolar disorder. Prostagal Leucotr. Essent Fatty Acids. 60, 329–37.

Stordy B.J. (1995). Benefit of docosahexaenoic acid supplements to dark adaptation in dyslexic. Lancet ii, 386.

Tobias P.V. (1995). Lecture University College London November 14.

Verhaegen M. Puech P.F. (2000). Hominid lifestyle and diet: paleo-enviromental and comparative data. Human Evolution, 15, 151–62.

Voskuyl R.A. Vreugdenhil M. Kang J.X. Leaf A. (1998). Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Euro J Pharmacol 341, 145–52.

Yao J.K. Leonard S. Reddy R.D. (2000). Abnormal phospholipid abnormalities in postmortem brains from schizophrenic patients. Schiz Res, 42, 7–17.